Despite rapid advancements in meibomian gland imaging, osmolarity testing, and targeted prescription therapeutics, dry eye disease remains one of the most chronically underdiagnosed conditions in primary eye care. Newly published findings from the multinational NESTS (Needs Unmet in Dry Eye: Symptoms, Treatment and Severity) survey commissioned by Bausch + Lomb reveal a vast population of sufferers who normalize daily ocular discomfort while delaying professional clinical care.
Inside the Two-Phase Multinational NESTS Cohort
To capture an unfiltered picture of how patients perceive and manage ocular surface distress, the NESTS investigation evaluated 5,152 adults across two distinct methodological phases. Phase I examined a general population sample of 2,580 adults, while Phase II drilled down into 2,572 age-, gender-, and geography-matched individuals experiencing self-reported dry eye symptoms across the United Kingdom, France, Germany, Poland, and Saudi Arabia.
Led by refractive surgeon and ocular surface specialist Dr. Piotr A. Wozniak, the study uncovered a stark epidemiological reality: self-reported dry eye symptoms are significantly more prevalent than formal healthcare professional diagnoses. Because patients frequently blame screen fatigue, dry indoor heating, or seasonal allergies for their fluctuating vision and gritty sensation, they routinely self-medicate with non-specific over-the-counter drops rather than booking a diagnostic workup.
Closing the diagnostic gap: findings from the 5,152-participant NESTS survey reveal that millions of patients endure daily tear-film instability without ever receiving a formal clinical diagnosis.
Functional Impairment Across Work and Daily Life
Far from being a minor cosmetic nuisance, unmanaged tear-film instability inflicts measurable damage on daily visual performance and workplace productivity:
- Pervasive Daily Symptomatology: A high proportion of symptomatic respondents reported experiencing burning, foreign-body sensation, or transient blur every single day without clinical oversight.
- Digital & Occupational Friction: Sufferers cited pronounced difficulty sustaining prolonged computer work, reading fine print, and driving safely at night due to tear film break-up.
- Delayed Clinical Presentation: Many patients waited months or years before mentioning ocular discomfort to an eye care provider, assuming their symptoms were an inevitable byproduct of modern digital lifestyles.
“When patients attribute chronic ocular surface pain to screen time or winter air, they delay intervention while meibomian gland architecture silently deteriorates.”
Actionable Protocols for Canadian Optometric Practices
For Canadian optometrists—whose patients contend with both high digital screen exposure and harsh, low-humidity winter heating seasons—the NESTS findings underscore the urgency of standardized intake screening. Waiting for a patient to volunteer complaints of dryness leaves a majority of mild-to-moderate disease undetected until contact lens dropout or pre-operative biometry errors occur.
Integrating validated symptom questionnaires (such as DEQ-5 or OSDI) alongside routine non-invasive tear break-up time (NIBUT) and meibography during comprehensive exams allows clinicians to intercept ocular surface disease early and establish long-term therapeutic compliance.
Key Takeaways
- The two-phase NESTS study surveyed 5,152 adults, demonstrating that daily dry eye symptoms far outpace formal clinical diagnoses.
- Untreated sufferers report substantial functional impairment in workplace screen use, reading stamina, and nighttime driving.
- Proactive chairside screening and patient education are essential to transition self-medicating consumers into structured ocular surface care.
